These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is seropositivity enough to show the association between coronary artery disease and Chlamydia pneumoniae and Helicobacter pylori infection? Yetkin G Int J Cardiol; 2006 Nov; 113(3):432-4. PubMed ID: 16325945 [No Abstract] [Full Text] [Related]
4. Helicobacter species in the atherosclerotic plaques of patients with coronary artery disease. Izadi M; Fazel M; Sharubandi SH; Saadat SH; Farahani MM; Nasseri MH; Dabiri H; SafiAryan R; Esfahani AA; Ahmadi A; Jonaidi Jafari N; Ranjbar R; Jamali-Moghaddam SR; Kazemi-Saleh D; Kalantar-Motamed MH; Taheri S Cardiovasc Pathol; 2012; 21(4):307-11. PubMed ID: 22104005 [TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and atherosclerosis: can current data be useful for clinical practice? Longo-Mbenza B Int J Cardiol; 2009 Jul; 135(3):e76-7. PubMed ID: 18649954 [No Abstract] [Full Text] [Related]
7. HELICOBACTER PYLORI AND ATHEROSCLEROSIS. Blum A Isr Med Assoc J; 2015 Jun; 17(6):396. PubMed ID: 26234008 [No Abstract] [Full Text] [Related]
8. [Helicobacter pylori and atherosclerosis. A review of the literature]. Franceschi F; Navarese EP; Mollo R; Giupponi B; De Marco G; Merra G; Gasbarrini G; Silveri NG Recenti Prog Med; 2009 Feb; 100(2):91-6. PubMed ID: 19350802 [TBL] [Abstract][Full Text] [Related]
9. Association between angiographic evidence of coronary artery disease and seropositivity for Helicobacter pylori and Chlamydia pneumoniae infection. Sharifkazemi MB; Marvasti VE; Hoseini E; Mohammadian R; Roshanzamir S; Ekramzadeh S; Rezayee V; Samim MM Saudi Med J; 2005 Apr; 26(4):684-5. PubMed ID: 15900388 [No Abstract] [Full Text] [Related]
11. Coronary artery disease and Helicobacter pylori infection: Should we consider eradication therapy as cardiovascular prevention strategy? Zuin M; Rigatelli G; Del Favero G; Picariello C; Meggiato T; Conte L; Faggian G; Zuliani G; Roncon L Int J Cardiol; 2016 Nov; 223():711-712. PubMed ID: 27573593 [No Abstract] [Full Text] [Related]
12. Role of infections in atherogenesis. Laroia ST; Ganti AK; Potti A Indian Heart J; 2003; 55(1):27-34. PubMed ID: 12760584 [No Abstract] [Full Text] [Related]
13. [Infections with Chlamydia pneumoniae, Helicobacter pylori or cytomegalovirus and atherosclerosis]. Grabczewska Z; Nartowicz E Przegl Lek; 1999; 56(9):584-7. PubMed ID: 10695364 [TBL] [Abstract][Full Text] [Related]
14. A Meta-Analysis of the Association between Helicobacter pylori Infection and Risk of Coronary Heart Disease from Published Prospective Studies. Sun J; Rangan P; Bhat SS; Liu L Helicobacter; 2016 Feb; 21(1):11-23. PubMed ID: 25997465 [TBL] [Abstract][Full Text] [Related]
15. Time for Routine Hofmann R; Bäck M Circulation; 2023 Jun; 147(23):1731-1733. PubMed ID: 37276250 [No Abstract] [Full Text] [Related]